This week we celebrate #NuclearMedicineWeek and all the nuclear medicine professionals that are revolutionizing healthcare. Through diagnostics, theranostics, molecular imaging and innovative techniques, nuclear medicine professionals are changing patient care and treatment. At RayzeBio, we are grateful for your passion, dedication and commitment to advancing patient outcomes. #RPTs #radiopharmaceuticals #gratitdue?
RayzeBio的动态
最相关的动态
-
This synthesis module is really incredible and easy to use. I can notice good yield and strength also with high activity.
ORA has a unique role in shaping the field of Nuclear Medicine. For over 16+ years we have been at the forefront of our field developing, designing, manufacturing, and supplying automated multi-purpose radiochemistry synthesizers to commercial clinical production and academic institutions. Today, ORA presents you the NEPTIS? xSeed.? The R&D module was developed keeping you; the radiochemist in mind, providing a cost saving solution to institutions and keeping a focus on making the production of your newly developed biomarker, time efficient. NEPTIS? providing customers solutions with innovative technology where needed. #NEPTIS #PET #NuclearMedicine #Healthcare #Synthesis #medicalresearch
-
-
Recently The Journal of Nuclear Medicine - JNM published the 6-month interim analysis from the EPIC-Skin study co-authored by GenesisCare clinicians, A/Prof Sid Baxi, Prof Angela Hong, and A/Prof Joe Cardaci. The aim of the interim analysis is to provide an early indication about the efficacy, safety, and associated patient-reported treatment comfort and quality of life outcomes following treatment of BCC and SCC with Rhenium SCT - a novel non-invasive radionuclide radiation therapy, provided in a single-session. To read the article, please click here: https://lnkd.in/eZKikXe5 #SkinCancer #NuclearMedicine #designingbettercare #clinicaltrials
-
-
Discover the power of precision with RSD's radiation equivalent and anatomically correct?Nuclear Medicine products! From anthropomorphic phantoms to radio isotopes, RSD is dedicated to enhancing diagnostics and improving patient outcomes. Together, let’s transform healthcare one scan at a time!?#NuclearMedicine #RSDphantoms #HealthcareInnovation #MedicalImaging #MolecularImaging #Theranostics #PatientCare #MedicalPhantoms #MedicalTechnology?#SNMMI
-
Preparing to outfit your #NucMed department soon or in the future? Join an upcoming #webinar, where you’ll get a detailed look at our portfolio of products for your current and forthcoming Nuclear Medicine, Radiopharmacy and Theranostics needs. Learn about our safety-enhancing and efficiency-gaining solutions for physicians, technologists and physicists—from diagnostic tools like dose calibrators to #HealthPhysics radiation monitoring solutions to QA phantoms and more. Save your spot >> https://hubs.li/Q02HHxPs0
-
-
Know Before You Go If you have a nuclear imaging test coming up- this is information that you need to know. There is a case report that underscores the need for constant vigilance in administering radiopharmaceuticals. Large extravasations can lead to serious harm. Let's ensure patient safety in #nuclearmedicine Time is critical, as over 2,000 patients in the US receive radiation doses similar to those in the case report daily. A published case report demonstrates the critical need for H.R. 6815, the Nuclear Medicine Clarification Act. https://lnkd.in/gJ55ueeq https://lnkd.in/gMT97fTj On September 12th HER HEALTHX is hosting a panel to talk about cancer and will have a patient’s story about extravasations. Together we can make change happen. #womenshealth #medicalgaslighting Cathleen Dohrn, PhD Joni Bradley Melanie Neal Kari Lato
-
-
First-in-Human Pb-212-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant #Prostatecancer. #research #radiotheranostics #radiopharmaceuticals #PSMA #pb212 The Journal of Nuclear Medicine - JNM
-
Yesterday we were delighted to participate in the Belgian EU Presidency Workshop: Securing Access to Radiopharmaceuticals for all European Patients during which Cristiana Gameiro was honored to present the innovative accelerators: pioneering technologies for advanced radioisotope production. This workshop featured very interesting presentations about radiopharmaceuticals' availability in Europe, regulatory framework and so inspiring patient testimonials treated by innovative radionuclide therapies. Is the Nuclear Medicine community in Europe ready for the future? Let's start the discussion in the comments! Belgian Presidency of the Council of the European Union 2024 #radiopharmaceuticals #radionuclide #cyclotron #EU2024BE
-
-
We are a podcast dedicated to the Radiology profession that highlights the Radiologist Assistant role as part of the industry and the patients we all serve together.
This is extremely important for getting our patient the care and imaging they need that is detrimental for their treatment and planning. Write your legislators today! Don’t have time; they did the work for you! Did it from my phone in less than 30 seconds! #patientcare #accesstocare #supportingpatientneeds #submityoursupport #nuclearmedicine #legislation #timewellspent
Last month, professionals and advocates from all of the country gathered at Capitol Hill, we educated and advocated on the impact of three important topics. The first topic was THE FIND ACT. The FIND ACT is now more important than ever as the field of Nuclear Medicine and Molecular Imaging has entered an era of growth furthering the sector of precision medicine. However, due to CMS bundling our specialized isotopes as a "supply", many organizations cannot absorb the financial loss. This has limited access to this care. The organizations that do perform the more specialized imaging, either absorb the cost or switch to the latest radiopharmaceutical coming out for commercial use because of pass through. <---- this in particular is bothersome as we should switch as the radiopharmaceuticals IMPROVE patient outcomes not because CMS establishes a limited reimbursement window. Please follow the link below to send a pre-drafted letter to your state legislators.
-
Former Chief Medical Officer, Vice President of Nuclear Medicine, and long-time academic physician—that's our in-house nuclear medicine expert, Alexander (Sandy) J.B. McEwan, MB, MSc, FRCPC. From research and publications in the academic space to hands-on development of novel SRTs, Sandy’s expertise is as developed as it is broad. Join Sandy and host Colin Miller, PhD, FIPEM, CSci Miller on this episode of Fractals to hear key insights on:?? ? The evolving landscape of nuclear medicine, radioisotope therapy, and radiopharmaceuticals in light of technological advancements, and a glimpse into their future.?? ? Defining success metrics in nuclear medicine and how they are influenced by treatment modalities.? ? The collaborative potential between industry and academia in advancing groundbreaking treatments and introducing new options for patients.? ? The importance of prioritizing patient-centered approaches in the advancement of radiopharmaceutical therapies.? Listen to the episode now: https://lnkd.in/e_86SVen #NuclearMedicine #Radiopharmaceuticals #RadioisotopeTherapy #PatientCare #LifeSci #FractalsLifeScienceConversations
Episode 7: The Necessity of Nuclear Medicine: Radiopharmaceutical Development and Translational Decision-Making with Guest Sandy McEwan
thebrackengroup.com
-
How Do #Radiopharmaceuticals Enhance #DiagnosticImaging and Treatment in Nuclear Medicine? Radiopharmaceuticals are unique drugs that combine radioisotopes with specific molecules to target organs or tissues in the body. Used in nuclear medicine, they enable #diagnosticimaging and treatment by emitting radiation detectable by equipment like #PETscanners, allowing healthcare professionals to visualize, evaluate, and treat various medical conditions effectively. Read More: https://lnkd.in/dpkscn6i #AMR #Radiopharmaceuticals #NuclearMedicine #DiagnosticImaging #MedicalInnovation #Healthcare #PETScan #Radioisotopes #MedicalTreatment #FunctionalImaging #HealthcareTechnology
